Comparative evaluation of the antagonistic activity of collection lactobacilli against the multidrug-resistant Klebsiella pneumoniae
AbstractTaking into account the known data on the high prevalence of multi-drug-resistant Enterobacteriaceae, such as Klebsiella spp., enterohemorrhagic Escherichia coli, and their properties to maintain viability in fermented milk products when using technologies in which, along with starter microorganisms, some enterobacteria with increased resistance to environmental factors (primarily active acidity) can survive and even multiply, the search for new strains of lactic acid probiotic bacteria with a pronounced antimicrobial effect are currently one of the most relevant areas of research in food biotechnology. Representatives of the Lactobacillus genus are currently considered as the most promising objects for the search for producers with probiotic properties. Their antagonistic activity is an important condition for ensuring the biological safety of foods created using fermentation and for developing effective measures to combat conditionally pathogenic and pathogenic microorganisms of the highest priority in terms of epidemiological significance.
The aim of the research was to study the antagonistic activity of collectible probiotic Lactobacillus strains in relation to multi-resistant Klebsiella pneumoniae, to assess their suitability in the production of specialized fermented milk products.
Material and methods. To determine the antagonistic activity of Lactobacillus collection strains in relation to the Klebsiella pneumoniae strain, two methods were used: co-cultivation and diffusion into agar using wells.
Results. As a result of the study of 2 strains of lactic acid bacteria – Lactobacillus helveticus NK1 and Lactobacillus (Lacticaseibacillus rhamnosus) rhamnosus F as antagonists against Klebsiella pneimopiae hospital strain, characterized by multiresistance to antibiotics of different groups, the high efficacy of the L. rhamnosus F. strain was confirmed. Antagonistic activity of the L. helveticus NK1 strain was insignificant, which suggests the variability of Klebsiella and the importance of searching for an antagonist strain with the widest possible spectrum of action.
Conclusion. The confirmed high antagonistic activity of the L. rhamnosus F strain makes it possible to recommend it for inclusion in starter cultures. The prospects of using the L. rhamnosus F strain, including for the production of fermented milk products for therapeutic nutrition and other special dietary uses, and for use in the diets of people with dysbiotic disorders, patients with intestinal infections, in particular, caused by multi-resistant strains of Klebsiella pneumoniaе, related to nosocomial infections, are shown. However, further research is needed to determine (identify) the mechanisms of the antimicrobial action of L. rhamnosus F. strain.
Keywords:antagonistic activity; dysbiosis; Klebsiella pneumoniaе; Lactobacillus
Funding. The study was not sponsored.
Conflict of interest. The authors declare no conflict of interest.
Сontribution. Research concept – Rozhkova I.V., Yurova E.A.; data collection – Terekhova R.P., Kishilova S.A.; data processing, text writing – Kishilova S.A.; editing, approval of the final version of the article, responsibility for the integrity of all parts of the article – all authors.
For citation: Kishilova S.A., Terekhova R.P., Rozhkova I.V., Yurova E.A. Comparative evaluation of the antagonistic activity of collection lactobacilli against the multidrug-resistant Klebsiella pneumoniae. Voprosy pitaniia [Problems of Nutrition]. 2023; 92 (6): 120–7. DOI: https://doi.org/10.33029/0042-8833-2023-92-6-120-127 (in Russian)
References
1. Mogna L., Deidda F., Nicola S., Amoruso A., Del Piano M., Mogna G. In vitro inhibition of Klebsiella pneumoniae by Lactobacillus delbrueckii subsp. delbrueckii LDD01 (DSM 22106): an innovative strategy to possibly counteract such infections in humans? J Clin Gastroenterol. 2016; 50 (suppl 2): S136–9. DOI: https://doi.org/10.1097/MCG.0000000000000680
2. Schagenyan I.A., Chernukha M.Yu. Infections caused by nonfermenting gram-negative rods: epidemiological, microbiological and clinical features. Klinicheskaya mikrobiologiya i antimikrobnaya khimioterapiya [Clinical Microbiology and Antimicrobial Chemotherapy]. 2005; 7 (3): 271–85. (in Russian)
3. Damian M., Usein C.R., Palade A.M., Ceciu S., Cosman M. Molecular epidemiology and virulence characteristics of Klebsiella pneumoniae strains isolated from hospital-associated infections. Open Epidemiol J. 2009; 2: 69–78. DOI: https://doi.org/10.2174/1874297100902010069
4. Gabrielyan N.I., Gorskaya E.M., Romanova N.I., Tsirul’nikova O.M. Nosocomial infection and microbial biofilms in surgery. Vestnik transplantologii i iskusstvennykh organov [Bulletin of Transplantology and Artificial Organs]. 2012; 14 (3): 83–91. DOI: https://doi.org/10.15825/1995-1191-2012-3-83-91 (in Russian)
5. Kornienko E.A. Gut microbiota and probiotic therapy possibilities in inflammatory bowel diseases. Farmateka [Pharmateca]. 2015; 2 (295): 39–43. (in Russian)
6. Ustyuzhanin A.V., Chistyakova G.N., Remizova I.I., Makhanek A.A. Genetic determinants of antibiotic resistance of enterobacteria isolated during microbiological monitoring in the perinatal center. Epidemiologiya i vaktsinoprofilaktika [Epidemiology and Vaccine Prophylaxis]. 2023; 22 (4): 49–55. DOI: https://doi.org/10.31631/2073-3046-2023-22-4-49-55 (in Russian)
7. Masuda N., Sakagawa E., Ohya S. Outer membrane proteins responsible for multiple drug resistance in Pseudomonas aeruginosa. Antimicrob Agents Chemother. 1995; 39 (3): 645–9. DOI: https://doi.org/10.1128/AAC.39.3.645
8. Bukharin O.V., Valyshev A.V., Cherkasov S.V. Persistent potential of conditionally pathogenic microorganisms. Epidemiologiya i vaktsinoprofilaktika [Epidemiology and Vaccine Prophylaxis]. 2005; (4): 43–8. (in Russian)
9. Romanova Yu.M., Gintsburg A.L. Bacterial biofilms as a natural form of existence of bacteria in the environment and host organism. Zhurnal mikrobiologii, epidemiologii i immunobiologii [Journal of Microbiology, Epidemiology and Immunobiology]. 2011; (3): 99–109. (in Russian)
10. Donlan R.M., Costerton J.W. Biofilms: survival mechanisms of clinically relevant microorganisms. Clin Microbiol Rev. 2002; 15 (2): 167–93. DOI: https://doi.org/10.1128/cmr.15.2.167-193.20
11. Sheveleva S.A. Antimicrobial-resistant microorganisms in food as a hygienic problem. Gigiena i sanitariya [Hygiene and Sanitation]. 2018; 97 (4): 342–54. DOI: https://doi.org/10.18821/0016-9900-2018-97-4-342-354 (in Russian)
12. Tutel’yan A.V., Yushina Yu.K., Sokolova O.V., Bataev D.S., Fesyun A.D., Datiy A.V. Formation of biological films of microorganisms in food productions. Voprosy pitaniia [Problems of Nutrition]. 2019; 88 (3): 32–43. DOI: https://doi.org/10.24411/0042-8833-209-10027 (in Russian)
13. Farrokh C., Jordan K., Auvra F., Glass K., Oppegaard H., Raynaud S., et al. Review of Shiga-toxin-producing Escherichia coli (STEC) and their significance in dairy production. Int J Food Microbiol. 2013; 162 (2): 190–212. DOI: https://doi.org/10.1016/j.ijfoodmicro.2012.08.008
14. Korotkevich Yu.V. Antibiotic resistance analysis of Enterococcus spp. and Enterobacteriaceae spp. isolated from food. Voprosy pitaniia [Problems of Nutrition]. 2016; 85 (2): 5–13. DOI: https://doi.org/10.24411/0042-8833-2016-00018 (in Russian)
15. Rozhkova I.V., Begunova A.V. Probiotic microorganisms as a factor in improving health. Molochnaya promyshlennost’ [Dairy Industry]. 2020; (7): 38–9. DOI: https://doi.org/10.31515/1019-8946-2020-06-38-39 (in Russian)
16. Sheveleva S.A. Medico-biological requirements to probiotic products and biologically active food supplements. Infektsionnye bolezni [Infectious Diseases]. 2004; 2 (3): 86–90. (in Russian)
17. Rozhkova I.V., Begunova A.V., Vasina D.V., Kubanova M.Kh., Krupenio T.V., Sharapchenko S.O., Gabrielyan N.I. Antagonistic activity of Lactobacillus spp. against hospital strains of Klebsiella spp. Vestnik transplantologii i iskusstvennykh organov [Bulletin of Transplantology and Artificial Organs]. 2018; 20 (S1): 180. DOI: https://doi.org/10.7868/S05551099118030054 (in Russian)
18. Fedorova T.V., Vasina D.V., Begunova A.V., Rozhkova I.V., Raskoshnaya T.A., Gabrielyan N.I. Antagonistic activity of lactic acid bacteria Lactobacillus spp. in relation to clinical isolates of Klebsiella pneumoniae. Prikladnaya biokhimiya i mikrobiologiya [Applied Biochemistry and Microbiology]. 2018; 54 (3): 264–76. DOI: https://doi.org/10.7868/S0555109918030054 (in Russian)
19. Savinova O.S., Glazunova O.A., Moiseenko K.V., Begunova A.V., Rozhkova I.V., Fedorova T.V. Exoproteome analysis of antagonistic interactions between the probiotic bacteria Limosilactobacillus reuteri LR1 and Lacticaseibacillus rhamnosus F and multidrug resistant strain of Klebsiella pneumonia. Int J Mol Sci. 2021; 22 (20): 10999. DOI: https://doi.org/10.3390/ijms222010999
20. Sukhina M.A., Shelygin Yu.A., Zhukhovitsky V.G., Frolov S.A., Kashnikov V.N., Veselov A.V., et al. Prospects of using antagonistic activity of lactobacilli to suppress the growth of Clostridium (Clostridioides) difficile. Eksperimental’naya i klinicheskaya gastoenterologiya [Experimental and Clinical Gastroenterology]. 2018; 160 (12): 19–24. DOI: https://doi.org/10.31146/1682-8658-ecg-160-12-19-24 (in Russian)
21. Samokhina L.S., Golovin M.A., Komolova G.S., Ganina V.I., Ionova I.I., Shatalova E.S. Antibacterial activity of lactoferrin from cow’s milk. Molochnaya promyshlennost’ [Dairy Industry]. 2012; (7): 56–7. (in Russian)
22. Onbas T., Osmanagaoglu O., Kiran F. Potential properties of Lactobacillus plantarum F-10 asabio-control strategy for wound infections. Probiotics Antimicrob Proteins. 2019; 11: 1110–23. DOI: https://doi.org/10.1007/s12602-018-9486-8
23. Ardatskaya M.D., Bel’mer S.V., Dobritsa V.P., Zakharenko S.M., Lazebnik L.B., Minushkin O.N., Oreshko L.S., et al. Colon dysbacteriosis (dysbiosis): modern state of the problem, comprehensive diagnosis and treatment correction. Experimental and clinical gastroenterology. Eksperimental’naya i klinicheskaya gastoenterologiya [Experimental and Clinical Gastroenterology]. 2015; 117 (5): 13–50. (in Russian)
24. Trukhan D.I. Disorders of intestinal microbiocenosis: expanding the application of probiotics. Meditsinskiy sovet [Medical Council]. 2022; 16 (7): 132–43. DOI: https://doi.org/10.21518/2079-701Х-2022-16-7-132-143 (in Russian)
25. Begunova A.V., Rozhkova I.V., Shirshova T.I., Krysanova Yu.I. Antimicrobial properties of Lactobacillus in fermented milk products. Molochnaya promyshlennost’ [Dairy Industry]. 2020; (6): 22–3. DOI: https://doi.org/10.31515/1019-8946-2020-06-22-23 (in Russian)
26. Simonenko E.S., Begunova A.V. Development of fermented milk product based on mare milk and lactic microorganisms association. Voprosy pitaniia [Problems of Nutrition]. 2021; 90 (5): 115–25. DOI: https://doi.org/10.33029/0042-8833-2021-90-5-115-125 (in Russian)
All articles in our journal are distributed under the CC BY-NC-ND 4.0 (Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International)
© GEOTAR-Media Publishing Group. The use of textual and illustrative content from this publication for the training of any artificial intelligence systems - including machine learning models and neural networks - is strictly prohibited without the prior written consent of the copyright holder.